1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-4-phenyl-5-(1-prop-2-enylpyrazol-4-yl)imidazole
C22H24N6O — CID 50967561
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-4-phenyl-5-(1-prop-2-enylpyrazol-4-yl)imidazole
1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-4-phenyl-5-(1-prop-2-enylpyrazol-4-yl)imidazole (PubChem CID 50967561) has the molecular formula C22H24N6O and a molecular weight of 388.48 g/mol. Its IUPAC name is 1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-4-phenyl-5-(1-prop-2-enylpyrazol-4-yl)imidazole.
Molecular Properties
| Compound Name | 1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-4-phenyl-5-(1-prop-2-enylpyrazol-4-yl)imidazole |
|---|---|
| PubChem CID | 50967561 |
| Molecular Formula | C22H24N6O |
| Molecular Weight | 388.48 g/mol |
| Exact Mass | 388.20 |
| IUPAC Name | 1-[[3-(2-methoxyethyl)imidazol-4-yl]methyl]-4-phenyl-5-(1-prop-2-enylpyrazol-4-yl)imidazole |
| SMILES | C=CCn1cc(-c2c(-c3ccccc3)ncn2Cc2cncn2CCOC)cn1 |
| InChI | InChI=1S/C22H24N6O/c1-3-9-28-14-19(12-25-28)22-21(18-7-5-4-6-8-18)24-17-27(22)15-20-13-23-16-26(20)10-11-29-2/h3-8,12-14,16-17H,1,9-11,15H2,2H3 |
| InChIKey | WRBLYIDREIOKIB-UHFFFAOYSA-N |
| XLogP | 3.49 |
| TPSA | 62.69 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 388.48 |
| LogP ≤ 5 | 3.49 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 50967561 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.